about
Virus-like particles production in green plantsHuman Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional PoreViral capsid proteins are segregated in structural fold spaceA replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeCell-free protein synthesis: applications come of age.Quantum dot-induced viral capsid assembling in dissociation buffer.Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centresHomologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Filovirus-like particles as vaccines and discovery tools.Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.Protection against filovirus infection: virus-like particle vaccines.Protection against lethal challenge by Ebola virus-like particles produced in insect cells.Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.The coming of age of virus-like particle vaccines.Prophylactic and therapeutic vaccines for obesity.Therapeutic vaccines for chronic diseases: successes and technical challenges.Influenza virosomes as vaccine adjuvant and carrier system.Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.Three-dimensional structure of foot-and-mouth disease virus and its biological functions.Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.Structural studies of MS2 bacteriophage virus particle disassembly by nuclear magnetic resonance relaxation measurements.Virus-like particle-based countermeasures against Rift Valley fever virus.Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments.Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates.Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.Biophysical chemistry: unravelling capsid transformations.A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study.
P2860
Q24650772-62BBA99B-EF6D-4720-AC12-C6CDA638D2DAQ27678128-CBD86903-80BF-408A-86E5-FD61DDB60867Q28486073-AD0440F6-6053-4A35-9744-E6FA51BD9DA4Q33621078-BCD41CD7-D878-42EF-B4C0-C0F1E59C6893Q33684275-679362E1-9530-4C71-B8F9-D02554035315Q34775491-ECEAD08C-6698-43C8-80AA-FEDE385F5844Q35082677-AEFCA13C-E134-4642-8DD5-6FC73081A1EDQ35202880-5E678C17-3B4A-40E0-98E0-3503CD3F6A19Q36198685-AE23CF77-A4F9-49DB-976F-79F00B46E711Q36370336-6EACAAEE-9C01-407B-860B-13960B62D4E2Q37038082-2A489993-18ED-4A62-83BA-52C2A10698E3Q37130463-E3BF2F1D-26F0-4172-90CC-7FCBBBACCBB7Q37131622-4DC5B177-C1DB-485B-82B1-371A34ADC21DQ37195802-11390289-17EB-47E5-AC80-6179C93C211FQ37309265-2661AA8B-0FFC-4D4F-B47A-A8A6AB9DC626Q37473523-BFD74D3E-D286-4C2C-AC9C-E4AB9195DC7BQ37926764-5E4A2AA9-F821-4DC6-BF3F-D76C353A7403Q38124062-6BEB8639-26A2-4C93-B015-050E89E603BDQ38217708-85820234-DA29-44B1-B692-C0D3FC79322EQ38265915-4AFE3D9C-6D05-41D3-A7C0-A20C04C0218BQ38840884-3F97352A-4C79-473E-958F-47F19141D5DBQ38998392-DF9E6738-FE73-4441-8357-37879F650ECDQ39068831-5FF98C7F-28ED-4DFC-9E77-882F32F2980AQ40182219-BDD27D31-67E7-4FD0-9915-1BB9B262AE59Q40239259-23B8DB9E-2B6F-4652-8152-C794CD532B25Q40254473-1485DCA0-15EB-4F33-BE56-43E468A57700Q40801586-8016B476-D403-4E15-B4EC-E9A0E104FCC5Q40801596-340C2BEC-04CE-4766-A358-9D23DDF7B873Q42233344-7767D495-6924-4CD1-9AC6-3ED66133030EQ44043287-8E101798-2ED8-4AE9-8E79-290569255F94Q44940478-F76AE1A9-99AB-447E-B71A-75C03BCA3EFDQ51625277-68E303AE-1B5D-4E6D-BF4A-66136F2227FE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Structures of virus and virus-like particles.
@ast
Structures of virus and virus-like particles.
@en
type
label
Structures of virus and virus-like particles.
@ast
Structures of virus and virus-like particles.
@en
prefLabel
Structures of virus and virus-like particles.
@ast
Structures of virus and virus-like particles.
@en
P1476
Structures of virus and virus-like particles.
@en
P2093
P304
P356
10.1016/S0959-440X(00)00073-7
P577
2000-04-01T00:00:00Z